Form D · Other

Novo Solutions, MD, L.L.C.

Scottsdale, AZ · CIK 0001517240

Offering snapshot reported Oct 17, 2012 · SEC filing

Reported sold
$1M
Offering amount: $1M
Investors reported
5
Form D · investor count
Minimum accepted
$40K
Reported outside-investor minimum
First sale
Jun 8, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$500K$1MJun 20, 2012: $120,000.00Jun 20, 2012Oct 17, 2012: $1,000,000.00Oct 17, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$120,000 → $1,000,000
  • Reported investors1 → 5
  • Minimum accepted$60,000 → $40,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 17, 2012Amendment$1,000,000$880,000vs Jun 20, 20125SEC filing
Jun 20, 2012Initial$120,000No comparison1SEC filing
Apr 18, 2011Initial$250,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-180063

Source: Form D, filed Oct 17, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark R. Engelman, Md Executive
Richard L. Johnes Executive

Issuer details

Industry: Other (See others in industry)

Address:
6710 N. Scottsdale Road Suite 240
Scottsdale, AZ, 85253